WESTLAKE CHEMICAL PARTNERS LP financials
$21.43−0.56%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $297.1M | $305.7M | $323.0M | $308.9M | $297.1M | $237.6M | $290.1M | $277.0M | $284.2M | $284.7M | $297.3M | $321.7M |
| Gross profit | $94.8M | $93.8M | $96.8M | $99.4M | $97.5M | $54.1M | $98.6M | $116.9M | $101.2M | $102.2M | $100.7M | $93.0M |
| Gross margin | 31.9% | 30.7% | 30.0% | 32.2% | 32.8% | 22.8% | 34.0% | 42.2% | 35.6% | 35.9% | 33.9% | 28.9% |
| Operating income | $87.3M | $86.6M | $89.8M | $92.0M | $91.2M | $46.6M | $92.0M | $109.7M | $93.6M | $95.1M | $92.8M | $86.2M |
| Net income | $14.2M | $14.2M | $14.5M | $14.7M | $14.6M | $4.9M | $15.0M | $18.1M | $14.4M | $14.8M | $14.3M | $13.2M |
| Net margin | 4.8% | 4.6% | 4.5% | 4.7% | 4.9% | 2.1% | 5.2% | 6.5% | 5.1% | 5.2% | 4.8% | 4.1% |
| Diluted EPS | $0.40 | $0.40 | $0.41 | $0.42 | $0.41 | $0.14 | $0.43 | $0.51 | $0.41 | $0.42 | $0.41 | $0.37 |
| EBITDA | $122.3M | $120.9M | $124.3M | $125.9M | $123.7M | $73.7M | $119.5M | $137.8M | $121.9M | $123.1M | $92.8M | $114.5M |
| Operating cash flow | $129.8M | $110.2M | $120.4M | $105.2M | $9.1M | $45.8M | $132.5M | $126.1M | $121.9M | $104.6M | $107.7M | $100.9M |
| Free cash flow | $117.4M | $104.6M | $111.5M | $75.6M | -$15.3M | $29.8M | $119.0M | $110.5M | $111.7M | $94.8M | $94.8M | $84.1M |
| Diluted shares | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $49.3M | $44.3M | $44.3M | $37.9M | $36.6M | $49.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $399.7M | $0.00 | $399.7M | $399.7M | $399.7M | $0.00 |
| Total assets | $1.22B | $1.24B | $1.26B | $1.27B | $1.31B | $1.37B |
| Total liabilities | $447.9M | $443.3M | $454.2M | $458.3M | $476.0M | $568.2M |
| Shareholders' equity | $769.4M | $792.4M | $802.4M | $813.3M | $831.2M | $803.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology